50 results
Page 2 of 3
PRE 14A
s8p05a001o5gxvi
10 Aug 20
Preliminary proxy
12:00am
10-K
c0covk0dqjp5 1riuz4d
29 Jun 20
Annual report
4:02pm
6-K
EX-99.1
sflod8y4wg7
9 Sep 19
Acasti Pharma Receives Funding from the Government of Canada to Expand Production Capacity
8:41am
6-K
EX-99.1
ez1t gun3cl
14 Aug 19
Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2020
12:00am
6-K
EX-99.1
onrpnkmf81k w50w
6 Aug 19
Notice of Annual and Special Meeting of Shareholders
12:00am
6-K
EX-99.1
y2ma0gz485sh9wt moby
15 Apr 19
Acasti Pharma Announces TRILOGY 1 Trial Has Achieved 100% Patient Randomization in  Patients with Severe Hypertriglyceridemia
9:15am
6-K
EX-99.1
5uc9y kglnae393p
24 Sep 18
Acasti Pharma Appoints Jean-François Boily as Vice President of Finance
8:05am
6-K
EX-99.2
qryfw 7g2gh66hwwipq
1 Aug 18
Notice of Annual and Special Meeting of Shareholders
12:00am
6-K
EX-99.1
xi28s8
27 Jun 18
Current report (foreign)
5:27pm
6-K
EX-99.1
evjq8dolz3
5 Jun 18
Acasti Pharma Appoints Brian Groch as Chief Commercial Officer
12:00am
6-K
EX-99.2
1vrnb8bknrhh
17 Jul 17
Notice of Annual and Special Meeting of Shareholders
12:00am
6-K
EX-99.1
pdbhv9
13 Jan 15
Current report (foreign)
12:00am
6-K
EX-99.1
x1mq46a0usfqyfnp4
14 Oct 14
Current report (foreign)
12:00am
6-K
EX-99
2mpx97v8dz w0n5z3
14 Oct 14
Form 6-K Filing Document
12:00am
6-K
EX-99
ayzcu2ld7368gv koohe
16 Jul 14
Form 6-K Filing Document
12:00am